| Ticker Details |
Masimo Corporation Common Stock
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
|
| IPO Date: |
August 8, 2007 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$9.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.31 | 1.43%
|
| Avg Daily Range (30 D): |
$1.98 | 1.44%
|
| Avg Daily Range (90 D): |
$2.11 | 1.50%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.45M |
| Avg Daily Volume (30 D): |
1.47M |
| Avg Daily Volume (90 D): |
.9M |
| Trade Size |
| Avg Trade Size (Sh.): |
72 |
| Avg Trade Size (Sh.) (30 D): |
69 |
| Avg Trade Size (Sh.) (90 D): |
55 |
| Institutional Trades |
| Total Institutional Trades: |
8,986 |
| Avg Institutional Trade: |
$5.13M |
| Avg Institutional Trade (30 D): |
$8.51M |
| Avg Institutional Trade (90 D): |
$8.47M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.93M |
| Avg Closing Trade (30 D): |
$22.91M |
| Avg Closing Trade (90 D): |
$16.88M |
| Avg Closing Volume: |
63.84K |
|
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$-10.62
|
$-1.86
|
$.95
|
|
Diluted EPS
|
$-10.56
|
$-1.84
|
$.94
|
|
Revenue
|
$2.18B
|
$371.5M
|
$370.9M
|
|
Gross Profit
|
$1.08B
|
$230.6M
|
$233.3M
|
|
Net Income / Loss
|
$-569.4M
|
$-100.4M
|
$51.3M
|
|
Operating Income / Loss
|
$-173.9M
|
$83.6M
|
$64.5M
|
|
Cost of Revenue
|
$1.11B
|
$140.9M
|
$137.6M
|
|
Net Cash Flow
|
$151.7M
|
$118.3M
|
|
|
PE Ratio
|
|
|
|
|
|
|